BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8091822)

  • 1. [The anti-ischemic effect of phosphodiesterase III inhibitors].
    Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():27-36. PubMed ID: 8091822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
    Mitrovic V; Oehm E; Minge C; Thürmann P; Schlepper M
    Z Kardiol; 1994 Jun; 83(6):431-8. PubMed ID: 7915067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
    Holubarsch C; Pieske B; Hasenfuss G; Just H
    Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of retard gallopamil in patients with stress-induced ST-segment depression and silent myocardial ischemias].
    Barbato G; Klein H; Lichtlen PR
    Z Kardiol; 1989; 78 Suppl 5():98-102. PubMed ID: 2698571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the prostacyclin analog taprostene on ischemic ST-segment depression in the stress ECG of coronary patients].
    Hopf R; Schöfl E; Frings M; Söhngen W
    Z Kardiol; 1994 Apr; 83(4):258-63. PubMed ID: 8023538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of 75 mg retard gallopamil on stress-induced myocardial ischemia].
    Sinn R; Wolf R
    Z Kardiol; 1989; 78 Suppl 5():83-8. PubMed ID: 2698568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute effects of enoximone after intracoronary administration on hemodynamics, myocardial perfusion and regional wall motion].
    Mitrovic V; Strasser R; Berwing K; Thormann J; Schlepper M
    Z Kardiol; 1996 Nov; 85(11):856-67. PubMed ID: 9064948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
    Mitrovic V; Schlepper M; Neuzner J; Bahavar H; Volz M; Dieterich HA
    Z Kardiol; 1988 Oct; 77(10):660-7. PubMed ID: 2977029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
    Grönefeld G; Bernhardt J; Schneider W
    Z Kardiol; 1993 Sep; 82(9):573-8. PubMed ID: 8237098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Hamm C
    Herz; 2000 Mar; 25(2):130-42. PubMed ID: 10829253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-pharmacologic aspects of therapy with enoximone].
    Trenk D; Jähnchen E
    Z Kardiol; 1994; 83 Suppl 2():7-14. PubMed ID: 8091828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isosorbide-5-mononitrate in silent ischemia].
    Pichler M; Brandt D; Teubl H; Dorda W
    Wien Klin Wochenschr; 1995; 107(13):390-5. PubMed ID: 7638969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
    Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
    Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of the phosphodiesterase III inhibitor in ischemic heart disease].
    Schlepper M; Mitrovic V; Thormann J
    Z Kardiol; 1991; 80 Suppl 4():75-83. PubMed ID: 1926997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of repetitive myocardial ischemia on collateral circulation, ST deviation and epicardial wall motion].
    Noike H; Ohsawa H; Uchi T; Kanai M; Yoshinuma M; Mineoka K; Hitsumoto T; Yokomuro H; Tokuhiro K; Tomioka H; Tachihara K
    J Cardiol; 1997 Feb; 29(2):73-83. PubMed ID: 9120796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gallopamil infusion for treatment of Prinzmetal angina].
    Carlon R; Cappelletti F; Ometto R; Maiolino P; Vincenzi M
    Cardiologia; 1990 May; 35(5):407-14. PubMed ID: 2125241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The electrocardiogram during physical stress and Holter monitoring in the detection of asymptomatic myocardial infarct].
    Damjanović MM
    Srp Arh Celok Lek; 1997; 125(11-12):340-4. PubMed ID: 9480567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.